Your browser doesn't support javascript.
loading
Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
Acta Pharmaceutica Sinica B ; (6): 1903-1918, 2023.
Article in En | WPRIM | ID: wpr-982834
Responsible library: WPRO
ABSTRACT
Interaction between tumour cells and macrophages enables cancer cells to evade immune detection and clearance by interfering with macrophage phagocytosis. The anti-phagocytic signals regulated by anti-phagocytic proteins are termed "don't eat me" signals; these signals include sialic acid-binding immunoglobulin-type lectin-10 (Siglec-10) and the recently revealed CD24 immune checkpoint (ICP). In this study, we demonstrate that targeting a specific glycan on CD24 exhibits the potential to inhibit ICP. Sambucus nigra agglutinin (SNA), a sialic acid-binding lectin, was employed to block CD24 and to enhance phagocytosis in melanoma tumours. In addition, we prepared SNA-conjugated hollow gold-iron oxide nanoparticles for photothermal therapy of tumours. Our findings show that the combination treatment of SNA-conjugated photothermal nanoparticles and near-infrared exposure successfully augments tumour cell phagocytosis both in vitro and in vivo models.
Key words
Full text: 1 Index: WPRIM Language: En Journal: Acta Pharmaceutica Sinica B Year: 2023 Type: Article
Full text: 1 Index: WPRIM Language: En Journal: Acta Pharmaceutica Sinica B Year: 2023 Type: Article